Procter & Gamble Health Q1 Results Live: Profit Rise by 25.56% YOY

Procter & Gamble Health Q1 Results Live : Procter & Gamble Health declared their Q1 results on November 4, 2024, showcasing a topline increase of 2.78% year-over-year, with profits soaring by 25.56%. This quarter's performance marks a significant improvement over the previous quarter, where revenue grew by 10.4% and profits surged by an astonishing 390.64%.

The company reported a decline in Selling, General & Administrative expenses, which fell by 4.96% quarter-over-quarter and decreased by 23.78% year-over-year, contributing to the enhanced profitability. This efficient cost management has allowed Procter & Gamble Health to bolster their operating income, which saw a remarkable increase of 418.04% sequentially and 31.75% on a year-over-year basis.

Earnings per share (EPS) for Q1 was reported at ₹49.6, representing a year-over-year increase of 25.57%. This solid EPS growth underscores the company’s robust financial health and operational efficiency.

In terms of stock performance, Procter & Gamble Health has delivered impressive returns of 10.59% in the last week, 16.75% over the past six months, and 15.19% year-to-date, indicating strong investor confidence in the company’s growth trajectory.

Currently, Procter & Gamble Health boasts a market capitalization of ₹9202.78 crore, with its stock trading within a 52-week range of ₹5742.4 at its high and ₹4636.55 at its low, reflecting a stable outlook amid market fluctuations.